Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
about
Interventions for improving adherence to treatment in cystic fibrosisCholinesterase inhibitors for deliriumMulti-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseMeta-analysis of continuous outcome data from individual patients.Meta-analysis of ordinal outcomes using individual patient data.To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data.Acetylcholinesterase inhibitors in Alzheimer's disease.Ongoing trials in Alzheimer's disease.Review of the acetylcholinesterase inhibitor galanthamine.Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression.Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?Therapy for Alzheimer's Disease: How Effective are Current Treatments?Further evidence for a dissociation between different forms of mnemonic expressions in a mouse model of age-related cognitive decline: effects of tacrine and S 17092, a novel prolyl endopeptidase inhibitorNeurobiology of butyrylcholinesterase.Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's disease.A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease.Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease.Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease.Gongjin-Dan Enhances Hippocampal Memory in a Mouse Model of Scopolamine-Induced Amnesia.Stigmatization in Alzheimer's disease research on African American elders.On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry.Optimum Design of Disease-modifying Trials on Alzheimer's Disease.ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy.Optimizing parameters in clinical trials with a randomized start or withdrawal designPredictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.The Electrophysiological Phenomenon of Alzheimer's Disease: A Psychopathology Theory.Current advances in transdermal delivery of drugs for Alzheimer's disease.Acetylcholinesterase Inhibitors: Treatment of Dementia-Related Behavioral Disturbances.Acetylcholinesterase inhibitors for Alzheimer's disease.Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.Zingipain, a ginger protease with acetylcholinesterase inhibitory activity.Check your microbiota when taking the drug.How much do persons with Alzheimer's disease cost Medicare?
P2860
Q24186754-84130614-5976-49AF-B7A7-65B548FA0CC0Q24242314-19B97CC5-8266-4ACF-8644-DD63B00C9D79Q26744105-62250DEB-AD1E-4389-8EEB-1B3C6F81A9F5Q30657054-6B2D9EA4-178D-471B-AB0F-9ABBF3005985Q30657056-B375BB88-197F-4CA5-894D-D7F9E380487EQ30676636-C55FBABA-30C5-47E1-AAB0-CB52E0079EC3Q33785568-E183B8F8-8ACB-4326-B626-E6645250E119Q34074827-772FF14D-0BAB-4BEA-BBD3-E550D80D75A6Q34075135-049AF777-6642-462E-9699-6D10F60F2F30Q34111025-C3181E80-8BD9-464B-ADAF-1FFCA0401850Q34146983-B9C0211A-794B-4928-B2DD-3663FE3A1C0BQ34409349-1901C292-8B8F-413D-AD85-DFAEA9BFE035Q35040005-FCA33B78-F444-44AB-8F1F-AF736C594D0DQ35058510-C4F7F48B-1FA5-4267-8E06-142577AAC41CQ35135672-E382D89D-2793-48EC-8B6B-DC507039FD83Q35236228-290D35E0-AF28-416F-A431-A59F35F478FCQ35465836-DDA6B1E4-AB90-4628-947E-B6AABC81AB39Q35748293-B4AC8B4C-E2E1-43E5-A43B-67906DBB2A95Q36092576-CDD65681-FC7E-4B8C-8D79-89194247DF96Q36311710-56B0A65B-F16B-4CB5-8F0C-D0252CC13745Q36723089-1541F7C8-67EF-4E9A-88F7-4F4FCADA4422Q36790787-061408BD-5C8A-48CD-A9FF-3A2136A486EBQ37043396-1B2896EE-E7C0-4F97-9676-FDD9B66FF364Q37244770-9FE741C6-0ECB-46D3-A300-280DC4A52486Q38396378-4E479B7D-1FB2-4741-BAA5-8C0BFDFA6487Q38588411-6D54F0D9-5CCC-44C3-9D6D-EC61BDC06AE3Q38657942-1DB7204C-BDF6-45D8-AF42-89BDDFE8F55AQ39853614-8A5CDD4F-094C-42B8-92B0-F9436875055CQ42761047-09A2065F-FFFE-4FE9-BFBA-E3BE8F3CD946Q44828253-2782A0E7-225F-4E98-9F46-F1AD2442F281Q44915865-6616D17F-AC78-4466-8BCB-E52EA875EC9FQ46117153-C945653B-EF02-43D9-958A-30F55D505E7CQ52922854-0094B670-FF06-4E94-8301-0B6944543AFB
P2860
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@ast
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@en
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@nl
type
label
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@ast
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@en
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@nl
prefLabel
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@ast
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@en
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@nl
P2093
P921
P356
P1476
Cholinesterase inhibition for ...... ntia Trialists' Collaboration.
@en
P2093
A Whitehead
L Schneider
N Qizilbash
P304
P356
10.1001/JAMA.280.20.1777
P407
P577
1998-11-01T00:00:00Z